BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Opko Health, Inc. 

4400 Biscayne Boulevard

Miami  Florida  33137  U.S.A.
Phone: 305-575-4100 Fax: n/a


SEARCH JOBS










 Company News
Opko Health, Inc. (OPK) Rockets After Striking Deal Worth $570 Million With Pfizer (PFE) 12/15/2014 6:28:00 AM
Opko Health, Inc. To Present At The Oppenheimer 25th Annual Healthcare Conference 12/3/2014 10:05:09 AM
Insider Buying: Phillip Md Et Al Frost Purchases 40,000 Shares Of Opko Health, Inc. Stock 11/25/2014 8:24:04 AM
Opko Health, Inc. Announces Third Quarter Operating And Financial Results 11/7/2014 9:48:13 AM
DSG, Inc. And Opko Health, Inc. Enter Into Enterprise Licensing Agreement For Fully Integrated EDC, IWRS, Safety, And Trial Management Solution 11/4/2014 10:38:33 AM
Neovasc Inc. (NVC), An Opko Health, Inc. Investee, Receives FDA Conditional Approval To Initiate TIARA-I Trial In U.S.: A Multinational, Multicenter Early Feasibility Trial Of The Tiaratm Transcatheter Mitral Valve 10/9/2014 11:04:18 AM
Opko Health, Inc. Supports National Prostate Cancer Council Legislation 9/29/2014 12:53:03 PM
Opko Health, Inc.'s Second Rayaldee Phase 3 Trial Meets Primary Endpoints 9/23/2014 10:57:13 AM
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Opko Health, Inc. Release: Rayaldee Phase 3 Trial Meets Primary Endpoints 8/12/2014 9:30:11 AM
12345678910...